Published in J Clin Hypertens (Greenwich) on September 25, 2014
Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure. Kidney Res Clin Pract (2016) 0.77
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J (2004) 2.09
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
Plasma renin activity and ischemic heart disease. N Engl J Med (1993) 1.71
Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Am J Hypertens (2011) 1.60
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. Am J Hypertens (2013) 1.57
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation (2005) 1.55
Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J (2007) 1.55
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens (1997) 1.41
A diurnal rhythm in plasma renin activity in man. J Clin Invest (1966) 1.32
Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. Mayo Clin Proc (2013) 1.31
Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients. Am J Hypertens (2011) 1.27
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension (2002) 1.23
Plasma renin activity and plasma prorenin assays. Clin Chem (1991) 1.16
Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem (2009) 1.12
25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich) (2010) 1.04
Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis (2011) 1.04
Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J Clin Endocrinol Metab (1975) 1.00
Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens (2004) 0.92
Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail (2010) 0.90
Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease. Am J Cardiol (2010) 0.88
Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort. J Hypertens (2011) 0.85
Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Eur Heart J (2012) 0.84
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens (2001) 0.81
Plasma renin activity in the emergency department and its independent association with acute myocardial infarction. Am J Hypertens (2000) 0.81
Review: Plasma renin and the incidence of cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2010) 0.81
"Effective" plasma renin activity: a derived measure for assessing residual plasma renin activity in patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Hypertension (2010) 0.77
Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure. Circ J (2007) 0.77
Cardiac angiotensin receptor expression in hypothyroidism: back to fetal gene programme? J Physiol (2007) 0.76
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol (2004) 8.97
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
Cachexia: a new definition. Clin Nutr (2008) 5.49
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med (2008) 4.98
Urologic diseases in America project: benign prostatic hyperplasia. J Urol (2005) 4.09
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med (2010) 3.78
Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol (2002) 3.68
Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care (2008) 3.08
The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol (2010) 3.08
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86
Redefinition of myocardial infarction: prospective evaluation in the community. Circulation (2006) 2.76
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74
Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc (2013) 2.72
Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71
Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol (2005) 2.69
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62
Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation (2005) 2.61
Does AKI truly lead to CKD? J Am Soc Nephrol (2012) 2.61
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res (2007) 2.56
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA (2011) 2.54
Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol (2004) 2.52
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med (2002) 2.51
Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr (2010) 2.46
Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol (2010) 2.42
Urologic diseases in america project: benign prostatic hyperplasia. J Urol (2008) 2.38
Teaching and learning responsible research conduct: influences of prior experiences on acceptance of new ideas. Account Res (2008) 2.38
Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc (2006) 2.37
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr (2007) 2.36
Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol (2003) 2.34
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA (2010) 2.30
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation (2006) 2.24
A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int (2013) 2.23
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med (2013) 2.18
Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care (2007) 2.18
Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant (2006) 2.15
Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med (2006) 2.09
Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol (2002) 2.06
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc (2002) 2.04
Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine (2011) 2.03
Population-based prevalence of repeated group A beta-hemolytic streptococcal pharyngitis episodes. Mayo Clin Proc (2006) 2.03
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health (2009) 2.03
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial (2014) 2.02
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res (2005) 2.02
Scores for post-myocardial infarction risk stratification in the community. Circulation (2002) 1.98
The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int (2009) 1.98
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc (2009) 1.98
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol (2006) 1.98
The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study. Arch Pediatr Adolesc Med (2005) 1.97
Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc (2009) 1.96
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol (2009) 1.92
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol (2013) 1.89
Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation (2012) 1.86
Temporal trends in the incidence of coronary disease. Am J Med (2004) 1.86
Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol (2009) 1.85
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr (2013) 1.85
Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr (2009) 1.83
Math learning disorder: incidence in a population-based birth cohort, 1976-82, Rochester, Minn. Ambul Pediatr (2005) 1.83
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis (2010) 1.82
Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis (2012) 1.81
Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis (2008) 1.78
Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol (2006) 1.76
Heart failure after myocardial infarction: a review. Am J Med (2002) 1.76
Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis (2011) 1.74
Seasonality and daily weather conditions in relation to myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, 1979 to 2002. J Am Coll Cardiol (2006) 1.73
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation (2007) 1.72
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol (2005) 1.70
Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab (2003) 1.69
Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol (2012) 1.67
Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation (2004) 1.67
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant (2006) 1.65
Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol (2002) 1.64